Sawant Ruta V, Lewing Benjamin, Wanat Matthew, Sansgiry Sujit S
Department of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, Health and Biomedical Sciences Building 2, 4849 Calhoun Rd, Houston, TX 77204, United States.
Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Health and Biomedical Sciences Building 2, 4849 Calhoun Rd, Houston, TX 77204, United States.
Curr Pharm Teach Learn. 2018 Sep;10(9):1197-1204. doi: 10.1016/j.cptl.2018.06.020. Epub 2018 Sep 6.
The study aimed to identify predictors of selection for on-site interview and admission into the doctor of pharmacy (PharmD) program using variables from the Pharmacy College Application Service (PharmCAS).
Admission data (de-identified) was obtained from University of Houston's College of Pharmacy for the years 2015 and 2016. The data consisted of relevant variables from the PharmCAS application system for all applicants during 2015 and 2016 admission cycles. Primary dependent variables were the admission committee decisions of (i) selection for on-site interview and (ii) admission into PharmD program. Descriptive frequency distributions, bivariate and multivariable logistic regression analyses were conducted to identify the predictors of admission decisions.
A total of 968 completed application records were obtained out of which 651 were selected for on-site interview and 413 were offered admission into the PharmD program. The logistic regression analyses indicated that as compared to pre-pharmacy grade-point-average (GPA) score of <3.2, applicants with a score of 3.2-3.49 (C.I 2.52-9.66) and ≥3.5 (C.I. 2.49-12.42) were more likely to be selected for interview. Applicants with pharmacy college admissions test (PCAT) score of 70-79 (C.I. 3.37-13.96) and ≥80 (C.I. 7.73-33.83) were more likely to be selected for interview as compared to those with PCAT < 70. With respect to admissions, female gender (C.I. 1.01-2.12), pre-pharmacy GPA ≥ 3.5 (C.I. 1.62-4.82), PCAT ≥ 80 (C.I. 2.33-6.61), letters of reference score ≥ 3.7 (C.I. 1.04-2.29) and at least one known additional language (C.I. 0.47-0.99) influenced the likelihood of being admitted into the PharmD program.
The study findings can be used to optimize the applicant review process by assigning more weightage to the significant predictors in decision making towards admission into PharmD programs. Future studies evaluating the influence of the predictors on academic performance are warranted.
本研究旨在利用药学院申请服务(PharmCAS)中的变量,确定进入现场面试和被药学博士(PharmD)项目录取的选择预测因素。
获取了休斯顿大学药学院2015年和2016年的录取数据(已去识别化)。数据包括2015年和2016年录取周期内所有申请人在PharmCAS申请系统中的相关变量。主要因变量是录取委员会关于(i)选择进入现场面试和(ii)被PharmD项目录取的决定。进行了描述性频率分布、双变量和多变量逻辑回归分析,以确定录取决定的预测因素。
共获得968份完整的申请记录,其中651人被选入现场面试,413人被PharmD项目录取。逻辑回归分析表明,与药学预科平均绩点(GPA)低于3.2的申请人相比,GPA为3.2 - 3.49(置信区间2.52 - 9.66)和≥3.5(置信区间2.49 - 12.42)的申请人更有可能被选入面试。与药学学院入学考试(PCAT)成绩低于70分的申请人相比,PCAT成绩为70 - 79(置信区间3.37 - 13.96)和≥80(置信区间7.73 - 33.83)的申请人更有可能被选入面试。关于录取,女性(置信区间1.01 - 2.12)、药学预科GPA≥3.5(置信区间1.62 - 4.82)、PCAT≥80(置信区间2.33 - 6.61)、推荐信分数≥3.7(置信区间1.04 - 2.29)以及至少掌握一门其他语言(置信区间0.47 - 0.99)影响了被PharmD项目录取的可能性。
本研究结果可用于优化申请人审核流程,在做出进入PharmD项目的录取决定时,对重要预测因素给予更大权重。有必要开展进一步研究,评估这些预测因素对学业表现的影响。